导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -20.31% | 4416/4773 |
| 近一周 | -3.64% | 4853/5465 |
| 近一月 | -10.72% | 5322/5421 |
| 近一季 | -23.40% | 5132/5231 |
| 近半年 | -21.98% | 4495/4920 |
| 近一年 | -12.89% | 3583/4394 |
| 近两年 | 56.96% | 1315/2954 |
| 近三年 | 13.02% | 1679/2253 |
| 成立以来 | 154.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.13% 2138/4961 |
-0.25% 3271/5312 |
- - |
- - |
| 2025 | 52.70% 405/4813 |
6.40% 641/3635 |
-1.13% 3118/4076 |
47.89% 422/4524 |
-1.85% 3027/4813 |
| 2024 | 1.47% 2009/3463 |
-6.29% 2039/2808 |
-9.29% 2346/3014 |
22.03% 512/3129 |
-2.18% 1994/3463 |
| 2023 | -27.44% 2007/2656 |
-2.69% 2040/2280 |
-5.45% 1459/2385 |
-14.93% 2203/2515 |
-7.30% 2111/2655 |
| 2022 | -27.37% 1472/2207 |
-16.52% 1136/1919 |
19.90% 68/2016 |
-23.13% 1961/2113 |
-5.62% 1944/2208 |
| 2021 | 42.98% 20/1822 |
-10.92% 1123/1255 |
44.15% 11/1330 |
11.39% 111/1466 |
-0.04% 1186/1822 |
| 2020 | 107.25% 13/1250 |
-6.07% 454/1028 |
27.11% 132/1067 |
17.11% 116/1164 |
48.22% 5/1184 |
| 2019 | 34.24% 411/1092 |
18.94% 636/754 |
-9.87% 699/804 |
5.03% 170/850 |
19.23% 7/918 |
| 2018 | - - |
- - |
- - |
- - |
-12.91% 493/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证新能源汽车产业指数(LOF)A VS. 长安沪深300非周期A(740101) |